Massachusetts
|
04-2911026
|
(State
or Other Jurisdiction of
|
(I.R.S.
Employer Identification No.)
|
Incorporation
or Organization)
|
Class
|
Number of Shares
Outstanding
|
Common
Stock, par value $0.01 per share
|
19,782,128
shares
|
Page
|
||
PART
I
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Unaudited
Consolidated Financial Statements
|
|
Consolidated
Balance Sheets as of June 30, 2009 and December 31,
2008
|
3
|
|
Consolidated
Statements of Operations for the Three and Six Months Ended June 30, 2009
and June 30, 2008
|
4
|
|
Consolidated
Statements of Cash Flows for the Three and Six Months Ended June 30, 2009
and June 30, 2008
|
5
|
|
Notes
to Consolidated Financial Statements
|
6
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
11
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
17
|
Item
4.
|
Controls
and Procedures
|
17
|
PART
II
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
18
|
Item
1A.
|
Risk
Factors
|
18
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
29
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
30
|
Item
6.
|
Exhibits
|
31
|
Signatures
|
31
|
June
30,
2009
|
December
31,
2008
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 31,860 | $ | 45,516 | ||||
Accounts
receivable, net
|
4,635 | 2,211 | ||||||
Inventories
|
1,128 | 1,656 | ||||||
Prepaid
expenses and other current assets
|
839 | 598 | ||||||
Total
current assets
|
38,462 | 49,981 | ||||||
Property
and equipment, net
|
7,165 | 7,463 | ||||||
Other
assets, net
|
68 | 102 | ||||||
Total
assets
|
$ | 45,695 | $ | 57,546 | ||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 535 | $ | 466 | ||||
Accrued
expenses
|
129 | 241 | ||||||
Accrued
compensation
|
1,276 | 1,480 | ||||||
Accrued
professional
|
198 | 167 | ||||||
Deferred
revenue
|
569 | 339 | ||||||
Total
current liabilities
|
2,707 | 2,693 | ||||||
Long-term
deferred revenue
|
330 | 330 | ||||||
Stockholders’
equity:
|
||||||||
Preferred
stock, $1.00 par value; 1,000,000 shares authorized, none
outstanding
|
- | - | ||||||
Common
stock, $.01 par value; 70,000,000 shares authorized; issued and
outstanding 19,782,128 as of June 30, 2009 and 23,281,204 as of
December 31, 2008
|
198 | 233 | ||||||
Additional
paid-in capital
|
75,030 | 83,143 | ||||||
Accumulated
deficit
|
(32,570 | ) | (28,853 | ) | ||||
Total
stockholders’ equity
|
42,658 | 54,523 | ||||||
Total
liabilities and stockholders’ equity
|
$ | 45,695 | $ | 57,546 |
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
June
30,
|
June
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Revenue:
|
||||||||||||||||
Product
sales
|
$ | 3,852 | $ | 3,948 | $ | 6,671 | $ | 7,872 | ||||||||
Contract
revenue
|
1,442 | 1,776 | 2,719 | 3,298 | ||||||||||||
Royalties
|
470 | 443 | 947 | 874 | ||||||||||||
Total
revenue
|
5,764 | 6,167 | 10,337 | 12,044 | ||||||||||||
Costs
and expenses:
|
||||||||||||||||
Cost
of product sales
|
1,043 | 624 | 1,556 | 1,448 | ||||||||||||
Cost
of contract revenue
|
909 | 1,129 | 1,817 | 2,148 | ||||||||||||
Research
and development
|
3,058 | 3,511 | 6,170 | 7,039 | ||||||||||||
Selling
and marketing
|
1,184 | 1,186 | 2,265 | 2,155 | ||||||||||||
General
and administrative
|
1,216 | 1,285 | 2,429 | 2,478 | ||||||||||||
Total
costs and expenses
|
7,410 | 7,735 | 14,237 | 15,268 | ||||||||||||
Loss
from operations
|
(1,646 | ) | (1,568 | ) | (3,900 | ) | (3,224 | ) | ||||||||
Interest
income
|
61 | 315 | 186 | 698 | ||||||||||||
Loss
before provision for income taxes
|
(1,585 | ) | (1,253 | ) | (3,714 | ) | (2,526 | ) | ||||||||
Provision
for income taxes
|
1 | 4 | 4 | 13 | ||||||||||||
Net
loss
|
$ | (1,586 | ) | $ | (1,257 | ) | $ | (3,718 | ) | $ | (2,539 | ) | ||||
Net
loss per share – basic
|
$ | (0.08 | ) | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.11 | ) | ||||
Net
loss per share – diluted
|
$ | (0.08 | ) | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.11 | ) | ||||
Weighted
average shares – basic
|
20,666 | 23,869 | 21,974 | 23,875 | ||||||||||||
Weighted
average shares - diluted
|
20,666 | 23,869 | 21,974 | 23,875 |
Six
Months Ended
|
||||||||
June
30,
|
||||||||
2009
|
2008
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
loss
|
$ | (3,718 | ) | $ | (2,539 | ) | ||
Adjustments
to reconcile net loss to net cash provided
by (used in) operating activities:
|
||||||||
Depreciation
and amortization
|
448 | 457 | ||||||
Stock
based compensation
|
800 | 718 | ||||||
Provision
for doubtful accounts
|
- | (19 | ) | |||||
Increase
(decrease) from changes in assets and liabilities:
|
||||||||
Accounts
receivable
|
(2,424 | ) | 1,986 | |||||
Inventories
|
528 | (646 | ) | |||||
Prepaid
expenses
|
(241 | ) | 135 | |||||
Accounts
payable
|
69 | 15 | ||||||
Accrued
expenses
|
(285 | ) | 22 | |||||
Deferred
revenue
|
230 | (94 | ) | |||||
Net
cash provided by (used in) operating activities
|
(4,593 | ) | 35 | |||||
Cash
flows from investing activities:
|
||||||||
Purchases
of property and equipment
|
(116 | ) | (274 | ) | ||||
Sales
of investments
|
- | 38,743 | ||||||
Purchases
of investments
|
- | (2,000 | ) | |||||
Net
cash provided by (used in) investing activities
|
(116 | ) | 36,469 | |||||
Cash
flows from financing activities:
|
||||||||
Proceeds
from issuance of common stock
|
3 | 337 | ||||||
Repurchase
of common stock
|
(8,950 | ) | (782 | ) | ||||
Net
cash used in financing activities
|
(8,947 | ) | (445 | ) | ||||
Increase
(decrease) in cash and cash equivalents
|
(13,656 | ) | 36,059 | |||||
Cash
and cash equivalents, beginning of period
|
45,516 | 1,806 | ||||||
Cash
and cash equivalents, end of period
|
$ | 31,860 | $ | 37,865 |
A)
|
Basis
of Presentation
|
The
accompanying unaudited consolidated balance sheet, statements of
operations, and statements of cash flows reflect all adjustments
(consisting only of normal recurring items) which are, in the opinion of
management, necessary for a fair presentation of financial position at
June 30, 2009, and of operations and cash flows for the interim periods
ended June 30, 2009 and 2008. Certain reclassifications have
been made to the prior year financial statements to conform to the current
year presentation.
|
|
The
accompanying unaudited consolidated financial statements have been
prepared in accordance with the instructions for Form 10-Q and therefore
do not include all information and footnotes necessary for a complete
presentation of our financial position, results of operations and cash
flows, in conformity with generally accepted accounting
principles. We filed audited financial statements which
included all information and footnotes necessary for such presentation for
the three years ended December 31, 2008 in conjunction with our 2008
Annual Report on Form 10-K.
|
|
The
results of operations for the interim period ended June 30, 2009 are not
necessarily indicative of the results to be expected for the year. We
evaluated subsequent events through July 31, 2009, the date of
financial statement issuance.
|
|
B)
|
Fair
Value Measurements
|
In
September 2006, the FASB issued SFAS No. 157 ("SFAS 157"), "Fair Value
Measurements". SFAS 157 defines fair value, establishes a
framework for measuring fair value in accordance with accounting
principles generally accepted in the United States, and expands
disclosures about fair value measurements. We adopted the provisions of
SFAS 157 as of January 1, 2008, for our financial instruments. Although
the adoption of SFAS 157 did not materially impact our financial
condition, results of operations, or cash flow, we are now required to
provide additional disclosures as part of our financial
statements.
|
|
SFAS
157 establishes a three-tier fair value hierarchy, which prioritizes the
inputs used in measuring fair value. These tiers include: Level
1, defined as observable inputs such as quoted prices in active markets;
Level 2, defined as inputs other than quoted prices in active markets that
are either directly or indirectly observable; and Level 3, defined as
unobservable inputs in which little or no market data exists, therefore
requiring an entity to develop its own assumptions.
|
|
For
recognition purposes, on a recurring basis we are required to measure
available for sale investments at fair value. We had no
available for sale investments as of June 30, 2009 or December 31,
2008.
|
|
Our
cash and cash equivalents, including money market securities, were $31.9
million and $45.5 million as of June 30, 2009 and December 31, 2008,
respectively. We classified our cash and cash equivalents within Level 1
of the fair value hierarchy because they are valued using quoted market
prices.
|
C)
|
Inventory
|
Inventories
are stated at the lower of cost or net realizable value with cost being
determined by the first-in, first-out (“FIFO”)
method. Inventory reserves are established for estimated excess
and obsolete inventory. Inventory consists primarily of the following (in
thousands):
|
June
30,
2009
|
December
31,
2008
|
||||||||
Raw
materials
|
$ | 1,127 | $ | 1,650 | |||||
Finished
goods
|
1 | 6 | |||||||
Total
|
$ | 1,128 | $ | 1,656 |
D)
|
Computation
of Earnings per Share
|
Basic earnings per share is
computed by dividing net income or loss by the weighted average number of
common shares outstanding. Diluted earnings per share is
computed by dividing net income or loss by the weighted average number of
common shares outstanding plus additional common shares that would have
been outstanding if dilutive potential common shares had been
issued. For the purposes of this calculation, stock options are
considered common stock equivalents in periods in which they have a
dilutive effect. Stock options that are anti-dilutive are
excluded from the calculation.
|
|
Net
loss per share is calculated as follows (in thousands, except per share
data):
|
Three
Months Ended
June
30,
|
Six
Months Ended
June
30,
|
||||||||||||||||
2009
|
2008
|
2009
|
2008
|
||||||||||||||
Net
loss
|
$ | (1,586 | ) | $ | (1,257 | ) | $ | (3,718 | ) | $ | (2,539 | ) | |||||
Weighted
average common shares outstanding
|
20,666 | 23,869 | 21,974 | 23,875 | |||||||||||||
Additional
dilutive common stock equivalents
|
- | - | - | - | |||||||||||||
Diluted
shares outstanding
|
20,666 | 23,869 | 21,974 | 23,875 | |||||||||||||
Net
loss per share – basic and diluted
|
$ | (0.08 | ) | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.11 | ) |
For
the three month periods ended June 30, 2009 and 2008 potential common
stock equivalents of 6,986 and 238,039, respectively, were not included in
the per share calculation for diluted EPS, because we had a net loss and
the effect of their inclusion would be anti-dilutive. For the six month
period ended June 30, 2009 and 2008 potential common stock equivalents of
3,377 and 448,568, respectively, were not included in the per share
calculation for diluted EPS, because we had net losses and the effect of
their inclusion would be
anti-dilutive.
|
For
the three month periods ended June 30, 2009 and 2008, options to purchase
7,564,743 and 4,455,998 shares of common stock, respectively, were
outstanding, but were not included in the computation of diluted EPS
because the options’ exercise prices were greater than the average market
price of the common stock and thus would be anti-dilutive. For
the six month periods ended June 30, 2009 and 2008, options to purchase
7,564,743 and 3,932,798 shares of common stock, respectively, were
outstanding, but were not included in the computation of diluted EPS
because the options’ exercise prices were greater than the average market
price of the common stock and thus would be
anti-dilutive.
|
|
E)
|
Stock-Based
Compensation
|
The
following table presents stock-based employee compensation expenses
included in the Company’s unaudited consolidated statements of operations
(in thousands):
|
Three
Months Ended
June
30,
|
Six
Months Ended
June
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Cost
of product sales
|
$ | 3 | $ | 3 | $ | 5 | $ | 6 | ||||||||
Cost
of contract revenue
|
36 | 26 | 68 | 60 | ||||||||||||
Research
and development
|
138 | 160 | 285 | 327 | ||||||||||||
Selling
and marketing
|
57 | 50 | 109 | 81 | ||||||||||||
General
and administrative
|
175 |
154
|
333 | 244 | ||||||||||||
Stock-based
compensation expense
|
$ | 409 | $ | 393 | $ | 800 | $ | 718 |
The
Company estimates the fair value of stock options using the Black-Scholes
valuation model. This valuation model takes into account the exercise
price of the award, as well as a variety of significant assumptions. These
assumptions used to estimate the fair value of stock options include the
expected term, the expected volatility of the Company’s stock over the
expected term, the risk-free interest rate over the expected term, and the
Company’s expected annual dividend yield. The Company believes that the
valuation technique and the approach utilized to develop the underlying
assumptions are appropriate in
calculating the fair values of the Company’s stock options granted in the
three and six months ended June 30, 2009 and June 30, 2008. Estimates of
fair value are not intended to predict actual future events or the value
ultimately realized by persons who receive equity
awards.
|
|
F)
|
Business
Segments
|
The
Company organizes itself as one segment and conducts its operations in the
United States.
|
|
The
Company sells its products and technology to domestic and international
customers. Revenues were generated from the following
geographic regions (in
thousands):
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
June
30,
|
June
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
United
States
|
$ | 3,578 | $ | 4,897 | $ | 6,103 | $ | 8,898 | ||||||||
Germany
|
1,534 | 856 | 2,568 | 2,371 | ||||||||||||
Rest
of World
|
652 | 414 | 1,666 | 775 | ||||||||||||
$ | 5,764 | $ | 6,167 | $ | 10,337 | $ | 12,044 |
G)
|
Income
Taxes
|
As
of December 31, 2008, we had federal net operating loss and research and
experimentation credit carryforwards of approximately $46.5 million and
$12.8 million respectively, which may be available to offset future
federal income tax liabilities and expire at various dates from 2009
through 2029. In addition, at December 31, 2008, we had
approximately $11.4 million and $6.6 million of state net operating losses
and state research and development and investment tax carryforwards,
respectively, which expire at various dates from 2009 through
2023.
|
|
Based on an analysis that we
performed under Internal Revenue Code Section 382 on our NOLs generated
for the period 1997 through 2007, we have not experienced a change in
ownership as defined by Section 382, and, therefore, the NOLs are not
currently under any Section 382 limitation.
|
|
H)
|
Recent
Accounting Pronouncements
|
In
May 2009, the FASB issued Statement of Financial Accounting Standards
(“SFAS”) No. 165, “Subsequent Events,” which establishes general
standards of accounting for and disclosure of events that occur after the
balance sheet date but before the financial statements are issued or are
available to be issued. SFAS No. 165 provides guidance on the period
after the balance sheet date during which management of a reporting entity
should evaluate events or transactions that may occur for potential
recognition or disclosure in the financial statements, the circumstances
under which an entity should recognize events or transactions occurring
after the balance sheet date in its financial statements and the
disclosures that an entity should make about events or transactions that
occurred after the balance sheet date. The Company adopted SFAS
No. 165 during the second quarter of 2009, and its application had no
impact on the Company’s consolidated financial
statements.
|
|
In
June 2009, the FASB issued Statement No. 168, The FASB
Accounting Standards Codification and the Hierarchy of Generally Accepted
Accounting Principles. Statement No. 168 replaces FASB
Statement No. 162, The Hierarchy of Generally Accepted Accounting
Principles, and establishes the FASB Accounting Standards Codification
TM (the Codification) as the source of authoritative accounting
principles recognized by the FASB to be applied by nongovernmental
entities in the preparation of financial statements in conformity with
generally accepted accounting principles (GAAP). Statement
No. 168 is effective for interim and annual periods ending after
September 15, 2009. The Company will begin to use the new
Codification when referring to GAAP in its quarterly report on
Form 10-Q for the fiscal period ending September 30, 2009.
This will not have an impact on the consolidated results of the
Company.
|
|
In
September 2006, the FASB issued SFAS No. 157 ("SFAS 157"),
"Fair Value Measurements," which defines fair value, establishes
guidelines for measuring fair value and expands disclosures regarding fair
value measurements. SFAS 157 does not require any new fair value
measurements but rather eliminates inconsistencies in guidance found in
various prior accounting pronouncements. SFAS 157 is effective for
fiscal years beginning after November 15, 2007. However, on February
6, 2008, the FASB issued FSP FAS 157-b which defers the effective
date of SFAS 157 for one year for nonfinancial assets and
nonfinancial liabilities that are recognized or disclosed at fair value in
the financial statements on a recurring basis. We adopted SFAS 157 on
January 1, 2008, except as it applies to those nonfinancial assets and
nonfinancial liabilities as noted in FSP FAS 157-b. We adopted FSP
FAS 157-b on January 1, 2009. The adoption of SFAS 157 did not have a
material impact on our consolidated financial position, results of
operations or cash
flows.
|
In
December 2007, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standard ("SFAS") No. 160, “Noncontrolling
Interests in Consolidated Financial Statements, an amendment of ARB No.
51.” SFAS 160 establishes accounting and reporting standards for the
noncontrolling interest in a subsidiary and for the deconsolidation of a
subsidiary. This accounting standard is effective for fiscal years
beginning after December 15, 2008. We adopted SFAS 160 on January 1, 2009.
The adoption of SFAS 160 did not have a material impact on our
consolidated financial position, results of operations or cash
flows.
|
|
In
December 2007, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standard ("SFAS") No. 141(R), “Business
Combinations.” SFAS 141(R) establishes principles and requirements for how
the acquirer recognizes and measures in its financial statements the
identifiable assets acquired, the liabilities assumed, an any
noncontrolling interest in the acquiree, recognizes and measures the
goodwill acquired in the business combination or a gain from a bargain
purchase, and determines what information to disclose to enable users of
the financial statements to evaluate the nature and financial effects of
the business combination. This accounting standard is effective for fiscal
years beginning after December 15, 2008. We adopted SFAS 141(R) on January
1, 2009. The adoption of SFAS 141(R) did not have a material impact
on our consolidated financial position, results of operations or cash
flows as of the date of adoption. SFAS 141(R) will be applied to any
future business combinations.
|
|
I)
|
Share
Repurchase Program
|
On
August 28, 2007, we announced a stock repurchase program to purchase up to
$5.0 million of our common stock, subject to market conditions and other
factors. Any purchases under our stock repurchase program may be made from
time to time without prior notice. On October 29, 2008, we announced that
the program had been amended to increase the total amount of common stock
that may be repurchased from $5.0 million to $10.0 million and to extend
the period of time that shares may be repurchased from December 31, 2008
to December 31, 2009. As of June 30, 2009, we had repurchased 721,131
shares of common stock at a total cost of $2.4 million under this program.
We did not repurchase any shares during the three and six month periods
ended June 30, 2009.
|
|
On
March 5, 2009, we announced a modified Dutch auction self-tender offer to
purchase up to 3,500,000 shares, or approximately 15%, of our outstanding
common stock (including the associated preferred share purchase rights),
at a price in the range of $2.20 to $2.60 per share, for a maximum
aggregate purchase price of approximately $9.1 million. The
terms of the tender offer also provided the right for us to purchase up to
an additional 2% of our shares if the offer was
oversubscribed.
|
|
The
tender offer closed on April 17, 2009, and on April 23, 2009 we
repurchased 3,500,252 shares at $2.50 per share for a total cost of $9.0
million, including expenses.
|
●
|
Cash
and cash equivalents, which consist of financial instruments with original
maturities of three months or less;
|
|
●
|
Short-term
investments, which consist of financial instruments with remaining
maturities of twelve months or less; and
|
|
●
|
Investments,
which consist of financial instruments that mature in three years or
less.
|
●
|
market
acceptance of broadband technologies we supply by semiconductor or
equipment companies;
|
|
●
|
the
extent and timing of new transactions with customers;
|
|
●
|
changes
in our and our customers’ development schedules and levels of expenditure
on research and development;
|
|
●
|
the
loss of a strategic relationship or termination of a project by a
customer;
|
|
●
|
equipment
companies' acceptance of integrated circuits produced by our
customers;
|
|
●
|
the
loss by a customer of a strategic relationship with an equipment company
customer;
|
|
●
|
announcements
or introductions of new technologies or products by us or our
competitors;
|
|
●
|
delays
or problems in the introduction or performance of enhancements or of
future generations of our technology;
|
|
●
|
failures
or problems in our hardware or software products;
|
|
●
|
price
pressure in the biometrics or test and diagnostics markets from our
competitors;
|
|
●
|
delays
in the adoption of new industry standards or changes in market perception
of the value of new or existing standards;
|
|
●
|
competitive
pressures resulting in lower contract revenues or royalty
rates;
|
|
●
|
competitive
pressures resulting in lower software or hardware product
revenues;
|
|
●
|
personnel
changes, particularly those involving engineering, technical, sales and
marketing personnel;
|
|
●
|
costs
associated with protecting our intellectual property;
|
|
●
|
the
potential that customers could fail to make payments under their current
contracts;
|
|
●
|
ADSL
or VDSL market-related issues, including lower ADSL or VDSL chipset unit
demand brought on by excess channel inventory and lower average selling
prices for ADSL or VDSL chipsets as a result of market
surpluses;
|
|
●
|
hardware
manufacturing issues, including yield problems in our hardware platforms,
and inventory buildup and obsolescence;
|
|
●
|
product
gross margin may be affected by various factors including, but not limited
to, product mix, product life cycle, and provision for excess and obsolete
inventory;
|
|
●
|
significant
fluctuations in demand for our hardware products;
|
|
●
|
new
laws, changes to existing laws, or regulatory developments;
and
|
|
●
|
general
economic trends and other
factors.
|
●
|
the
test and diagnostics, semiconductor, telecommunications or biometrics
markets decline;
|
|
●
|
new
and/or existing customers do not choose to use our software or hardware
products;
|
|
●
|
new
and/or existing customers do not choose to license and/or buy our patents;
or
|
|
●
|
new
and/or existing customers do not choose to license our silicon IP for new
chipset products or do not maintain or increase their revenues from sales
of chipsets with our
technology.
|
●
|
we
must typically undergo a lengthy and expensive process of building a
relationship with a potential customer before there is any assurance of an
agreement with such party, and in some instances we must convince a
potential customer to enter the DSL market.
|
|
●
|
we
must persuade semiconductor and equipment manufacturers with significant
resources to rely on us for critical technology on an ongoing basis rather
than trying to develop similar technology internally;
|
|
●
|
we
must persuade potential customers to bear development costs associated
with our technology applications and to make the necessary investment to
successfully manufacture chipsets and products using our technology;
and
|
|
●
|
we
must successfully transfer technical know-how to
customers.
|
●
|
market
acceptance of our biometric technologies and products;
|
|
●
|
changes
in contracting practices of government or law enforcement
agencies;
|
|
●
|
the
failure of the biometrics market to experience continued
growth;
|
|
●
|
announcements
or introductions of new technologies or products by our
competitors;
|
|
●
|
delays
or problems in the introduction or performance of enhancements or of
future generations of our technology;
|
|
●
|
failures
or problems in our biometric software products;
|
|
●
|
the
risk that current or potential customers might decide to develop their own
software rather than buy it from us;
|
|
●
|
delays
in the adoption of new industry biometric standards or changes in market
perception of the value of new or existing standards;
|
|
●
|
growth
of proprietary biometric systems which do not conform to industry
standards;
|
|
●
|
competitive
pressures resulting in lower software product revenues;
|
|
●
|
personnel
changes, particularly those involving engineering, technical and sales and
marketing personnel;
|
|
●
|
costs
associated with protecting our intellectual property;
|
|
●
|
litigation
by third parties for alleged infringement of their proprietary
rights;
|
|
●
|
the
potential that customers could fail to make payments under their current
contracts;
|
|
●
|
new
laws, changes to existing laws, or regulatory developments;
and
|
|
●
|
general
economic trends and other
factors.
|
●
|
our
ability to structure and price technology contracts in a manner that is
consistent with our business model;
|
|
●
|
our
ability to deliver contract milestones: i) in a timely and cost efficient
manner, and ii) in a form and condition acceptable to
customers;
|
|
●
|
the
risk that customers could terminate projects;
|
|
●
|
the
risk that we rely substantially on third party contractors and consultants
to deliver certain contract milestones; and
|
|
●
|
the
potential that customers could fail to make payments under their
contracts.
|
●
|
reduced
demand for our products or our customers’ products that incorporate our
technology;
|
|
●
|
increased
risk of order cancellations or delays;
|
|
●
|
increased
risk that customers may delay or terminate projects;
|
|
●
|
increased
pressure on the prices for our products or our customers’ products that
incorporate our technology;
|
|
●
|
greater
difficulty in collecting accounts receivable; and
|
|
●
|
risks
to our liquidity, including the possibility that we might not have access
to our cash when needed.
|
●
|
quarterly
fluctuations in our operating results;
|
|
●
|
changes
in future financial guidance that we may provide to investors and public
market analysts;
|
|
●
|
changes
in our relationships with our customers;
|
|
●
|
announcements
of technological innovations or new products by us, our customers or our
competitors;
|
|
●
|
changes
in DSL or biometrics market growth rates as well as investor perceptions
regarding the investment opportunity that companies participating in the
DSL or biometrics industry afford them;
|
|
●
|
changes
in earnings estimates by public market analysts;
|
|
●
|
key
personnel losses;
|
|
●
|
sales
of our common stock;
|
|
●
|
our
stock repurchase activities; and
|
|
●
|
developments
or announcements with respect to industry standards, patents or
proprietary rights.
|
Period
|
(a)
Total
Number of
Shares
Purchased
|
(b)
Average
Price
Paid
per Share
|
(c)
Total
Number of Shares
Purchased
as Part of
Publicly
Announced Plans
or
Programs(1) (2)
|
(d)
Maximum
Number (or
Approximate
Dollar
Value)
of Shares that
May
Yet Be Purchased
Under
the Plans
or
Programs
|
||||||||||||
April
1, 2009 to June 30, 20091
|
-
|
-
|
-
|
$ |
7,603,874
|
|||||||||||
April
1 to April 30, 20092
|
3,500,252
|
$ |
2.50
|
3,500,252
|
-
|
(1)
|
On
August 28, 2007, we issued a press release announcing that our board of
directors had approved the repurchase from time to time through December
31, 2008 of up to $5,000,000 of our common stock. On October 29, 2008, we
announced that our board of directors had approved an amendment to the
program that increased the total amount of common stock that may be
repurchased from $5,000,000 to $10,000,000. The amendment also
extended the period of time that shares may be repurchased from December
31, 2008 to December 31, 2009.
|
During
2007 and 2008, we purchased 9,107 and 712,024 shares, respectively, at a
total cost of $38,716 and $2,357,410, respectively, under this plan. We
did not purchase any shares under the plan in the first six months of
2009.
|
|
(2)
|
On
March 5, 2009, we announced a modified Dutch auction tender offer to
purchase up to 3,500,000 shares of our common stock at a price per share
of not less than $2.20 and not greater than $2.60. The terms of the tender
offer also provided the right for us to purchase up to an additional 2% of
our shares if the offer was oversubscribed. The tender offer
closed on April 17, 2009, and on April 23, 2009 we repurchased 3,500,252
shares at $2.50 per share for a total cost of $9.0 million, including
expenses.
|
(1)
|
Each
of G. David Forney, Jr., Charles K. Stewart and Michael A. Tzannes was
elected to serve as a Class I director of the Company for a term expiring
at the annual meeting of stockholders of the Company in 2012 or a special
meeting in lieu thereof. John K. Kerr, Mark G. McGrath, Adrian
F. Kruse and Edmund C. Reiter continued to serve as directors following
the Annual Meeting.
|
|
The
votes cast to elect the Class I directors
were:
|
Name
|
For
|
Withheld
|
G.
David Forney, Jr.
|
15,496,051
|
1,279,111
|
Charles
K. Stewart
|
15,498,040
|
1,277,122
|
Michael
A. Tzannes
|
16,121,735
|
653,427
|
(2)
|
The
Company’s existing equity plans were amended to allow for an option
exchange program for employees other directors and executive
officers.
|
|
The
votes cast to amend the Company’s existing equity plans
were:
|
For
|
Against
|
Abstain
|
Non Votes
|
7,814,195
|
2,958,366
|
15,172
|
5,987,429
|
Exhibit
31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
Exhibit
31.2
|
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
Exhibit
32.1
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to Section
906 of the Sarbanes-Oxley Act of
2002.
|
AWARE,
INC.
|
|||
Date:
July 31, 2009
|
By:
|
/s/ Michael A. Tzannes
|
|
Michael
A. Tzannes, Chief Executive
|
|||
Officer
|
|||
Date:
July 31, 2009
|
By:
|
/s/ Richard P. Moberg
|
|
Richard
P. Moberg, Chief Financial
|
|||
Officer
(Principal Financial and
Accounting
Officer)
|